catalyx space | $5,400,000 | (Nov 4, 2025)
Zeeg | $1,265,935 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
Amber Bio
United States
- San Francisco, CA
- 04/08/2023
- Seed
- $26,000,000
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations. The current paradigm in genetic medicine relies on developing independent therapies for each separate mutation in the patient population. Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is developing a first-of-its-kind RNA writing platform capable of editing thousands of diverse mutations across patients with a single product.
- Industry Pharmaceutical Manufacturing
- Website https://www.amber.bio/
- LinkedIn https://www.linkedin.com/company/amber-bio/about/
Related People
Jacob BorrajoCo Founder
United States -
San Francisco, California
My greatest interests are i) to build technologies to measure new properties of biological systems ii) to apply synthetic biology approaches to create solutions to health-related problems and iii) to develop hardware-free technology by replacing hardware-intensive processes with simplified biological analogs.
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
octonomy | $20,000,000 | (Nov 4, 2025)
Helex | $3,500,000 | (Nov 4, 2025)
Indomo | $25,000,000 | (Nov 4, 2025)
AUI™ (Augmented Intelligence) | $20,000,000 | (Nov 4, 2025)
Popai Health | $11,000,000 | (Nov 4, 2025)
Mem0 | $24,000,000 | (Oct 30, 2025)
FrontlineIQ | $3,300,000 | (Oct 30, 2025)